Marc Beer is the CEO, chairman, and co-founder of the Renovia Inc. He achieved his highest education merit from Miami University (Oxford, OH). Marc Beer has been influential in bringing a positive change in the health sector helping women with pelvic floor disorders a condition that is believed to affect 250 million worldwide. Marc Beer has excellent experience in biotechnology, pharmacy, and industrial diagnosis. He has served as an executive in the development and commercialization for over 25 years. Learn more: https://www.linkedin.com/in/marcbeer
Pelvic Floor Disorders affect 250 million people globally according to the National Health Institute. Marc Beer aspires to give hope to millions of patients affected by the condition. Marc Beer earned a Bachelor of Science from the Miami University, Ohio. He molded his career around innovation and technology, related to his are of specialization, biotechnology, and pharmaceuticals.
In 2016, Marc Beer founded, Renovia Inc, a leading health innovator. Marc Beer 25 years experience in the field makes him an expert in health innovation. Marc Beer Renovia Inc. CEO is determined to move on with the new products for pelvic floor disorders. This will be possible after Renovia Inc. under his leadership was able to close a $32million series B round and a $10 million venture debt. This will help in acquiring both diagnostic and therapeutic products for conditions such as urinary incontinence.
Marc Beer work at renovia is notable. Recently, he fundraised for Renovia a $42 million series B funding. In his words, he noted that the funding would go to financing the improvement and expansion of technology devices for treating pelvic floor disorders. The fund will also help in giving patients diagnosis and therapy. Marc Beer earlier this year obtained approval from the Food and Drug Administration to commercialize Lava a device used to diagnose and manage.
The funding will be channeled towards the testing of four more therapeutic and diagnostic products including the new generation of the Leva device. Renovia Inc. was able to achieve its first FDA product approval Leva, in April 2018. Marc Beer was definite and confident that the partnership with other health care investors would go a long way in helping to improve the lives and health of women affected by pelvic disorders. This was achievable through better diagnosis, and treatment. Beer believes that by combining innovation, proprietary sensor technologies and a digital health platform, the clients would be able to gate valuable data that is informative and knowledge impacting about pelvic floor disorders.
Earlier in the year, Renovia under the leadership of Marc Beer, obtained approval from the FDA to commercialize the devices. Renovia has been researching, developed and refined the apps with patients concerns at heart. Marc Beers’ determination to help women with pelvic floor disorders has seen him lead with positive energy and great vision, hence bringing in an irresistible change. His leadership has brought benefit to his customers.